PrevenTech Solutions
MGX-0024
MGX-0024 represents a paradigm shift in preventative anti-viral treatment. By leveraging a safe, broad-spectrum, and easy-to-use formulation, the company is addressing a critical global need for infection prevention in both human and veterinary health. With strong patent protection, compelling clinical data, and a clear pathway forward, MGX-0024 is positioned to revolutionize the way we protect against respiratory illnesses.
Innovation
•PrevenTech Solutions is a licensed distributor of MGX-0024, a proprietary, non-pharmaceutical, non-invasive antiviral formulation.
•Composed of GRAS (Generally Recognized As Safe) ingredients, including select tannin (plant-derived, enhanced polyphenol) and zinc.
•Designed to prevent viral infections by neutralizing viruses in the oral cavity and upper throat before they establish infection.
•Highly scalable solution that aligns with global health priorities.
•Provides proactive viral defense through everyday oral care products, to engender extreme user compliance.
Tech
- Effective against multiple respiratory viruses, including influenza (H1N1), coronaviruses, and common cold viruses.
- Unlike vaccines that target specific strains, MGX-0024 prevents infections from a wide range of pathogens.
- Composed of Generally Recognized as Safe (GRAS) ingredients, the formulation can be integrated into daily hygiene routines without side effects.
MGX-0024 has undergone in-vitro and in-vivo testing to validate its effectiveness.
U.S. Patent No. 11,517,523, with corresponding patents in the EU, Canada, China, India, Australia and Japan.